Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

[Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].

Zuidema SU, van Iersel MB, Koopmans RT, Verhey FR, Olde Rikkert MG.

Ned Tijdschr Geneeskd. 2006 Jul 15;150(28):1565-73. Review. Dutch.

PMID:
16886695
2.

Antipsychotics for delirium.

Lonergan E, Britton AM, Luxenberg J, Wyller T.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005594. Review.

PMID:
17443602
3.

The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Ballard C, Waite J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003476. Review.

PMID:
16437455
4.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
5.

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Schneider LS, Dagerman K, Insel PS.

Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210.

PMID:
16505124
6.

Atypical antipsychotics for the treatment of delirious elders.

Ozbolt LB, Paniagua MA, Kaiser RM.

J Am Med Dir Assoc. 2008 Jan;9(1):18-28. doi: 10.1016/j.jamda.2007.08.007. Review.

PMID:
18187109
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
9.

Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.

Aupperle P.

Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):101-8. Review.

PMID:
16634465
11.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
12.

[The use of antipsychotics in patients with dementia].

Forlenza OV, Cretaz E, Diniz BS.

Rev Bras Psiquiatr. 2008 Sep;30(3):265-70. Review. Portuguese.

13.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
14.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

15.

Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.

Boettger S, Jenewein J, Breitbart W.

Palliat Support Care. 2015 Aug;13(4):1079-85. doi: 10.1017/S1478951514001059. Epub 2014 Sep 5.

PMID:
25191793
16.

A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.

Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA.

Neuropsychopharmacology. 2004 Jan;29(1):133-45.

17.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
18.

Olanzapine: an updated review of its use in the management of schizophrenia.

Bhana N, Foster RH, Olney R, Plosker GL.

Drugs. 2001;61(1):111-61. Review.

PMID:
11217867
19.

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group.

J Clin Psychiatry. 2004 Mar;65(3):312-21.

PMID:
15096069
20.

Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.

Chiabrando G, Bianchi S, Poluzzi E, Montanaro N, Scanavacca P.

Eur J Clin Pharmacol. 2010 Jul;66(7):661-9. doi: 10.1007/s00228-010-0828-z. Epub 2010 May 13.

PMID:
20464383

Supplemental Content

Support Center